in MM.
Introduction
The root and stem bark of Magnolia has been used as a traditional Chinese and Japanese medicine for the treatment of thrombotic stroke, gastrointestinal complaints, and anxiety. Honokiol (HNK), an active component isolated and purified from Magnolia, has anti-oxidant, antithrombosis, antibacterial, xanthine oxidase inhibitory, and anxiolytic effects [1] [2] [3] [4] [5] . Previous reports have demonstrated that HNK induces apoptosis and inhibits the growth of leukemia cell lines HL-60 and Molt 4B; colon cancer cell line RKO; lung cancer cell line CH27; transformed endothelial cell line SVR; and has remarkable in vivo anti-tumor activity against skin tumors and SVR angiosarcoma in mouse model [6] [7] [8] [9] [10] [11] . To data, however, little is known about the precise mechanism of growth inhibition and apoptosis by HNK 10 .
Multiple myeloma (MM) is a B-cell malignancy characterized by proliferation of monoclonal plasma cell in bone marrow (BM). Despite clinical efficacy of high dose therapy as well as novel agents including thalidomide, revlimid and bortezomib in patients with relapsed and refractory MM, responses are not durable and few, if any, patients are only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013 . bloodjournal.hematologylibrary.org From heparinized peripheral blood by Ficoll-Hipaque density sedimentation. BM specimens were acquired from patients with MM after obtaining informed consent and mononuclear cells were separated by Ficoll-Hipaque density sedimentation. Cells were cultured at 37°C in RPMI1640 containing 10% fetal bovine serum (FBS; Sigma, St Louis, MO), 2 µM L-glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin (Gibco, Grand Island, NY).
MNCs in BM specimens were also used to establish long-term bone marrow stromal cell (BMSC) cultures, as described 15, 16 . For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From Cambridge, MA) was dissolved in DMSO at 1 mM. These reagents were stored at 20°C and diluted by media just before the use. Doxorubicin (Sigma, St Louis, MO) was dissolved in sterile water at the concentration of 3.45 mM and stored at 4°C. Arsenic trioxide (As 2 O 3 ; 5 mM in PBS) was provided by Cell Therapeutics Inc. (Seattle, WA) and stored at room temperature.
Reagents

Cellular proliferation and DNA synthesis assay
Colorimetric assays were performed to evaluate drug activity. MM cell lines and 
Cell cycle analysis
MM cells cultured with HNK were harvested, fixed with 70% ethanol, and pretreated with 250 µg/mL of RNAse (Sigma, St Louis, MO). Cells were stained with propidium iodide (PI; 50 µg/mL; Sigma, St Louis, MO), and cell cycle profile was determined by using the program M software on an EPICS XL flow cytometer.
Detection of apoptosis and caspase-3 activity
TdT-mediated d-UTP nick end labeling (TUNEL) assay (MBL, Nagoya, Japan) and APO 2.7 staining (Immunotech, Marseille, France) were used to determine apoptosis.
In brief, cells were fixed and permeabilzed by 4% paraformaldehyde and 70% ethanol, respectively, and incubated with a mixture of FITC-dUTP and TdT for 1 h at 37ዊ for TUNEL assay. For detection of mitochondrial membrane protein 7A6 expression on apoptotic cells, cells were incubated with APO 2.7 reagent for 20 minutes. Fluorescence intensity of TUNEL and APO 2.7 staining was determined using on EPICS XL flow cytometer. Cytotoxicity was determined by trypan blue exclusion assay. To evaluate activation of caspase 3, flow cytometric analysis was done using FITC-conjugated only.
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Western blotting
MM cells cultured under indicated conditions were harvested, washed twice with ice-cold PBS, and lysed in lysis buffer; 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 5 mM EDTA, 5 mM NaF, 2 mM Na 3 V 4 , 1 mM PMSF, 5 µg/ml leupeptine, and 5 µg/ml aprotinin for immunoblotting of whole cell lysate. Subcellular proteins from 1x10 7 of HNK treated cells were extracted using Nuclear/Cytosol fractionation kit (BioVision, Mountain View, CA). Cell lysates or fractionated proteins were subjected to SDS-PAGE, transferred to nitrocellulose membrane, and immunoblotted with these antibodies:
anti-caspase 3, -caspase 6, -caspase 7, -caspase 8, -caspase 9, Bad, phosphorylated (p)-Bad containing 2.5 % of FCS with 10 µg/ml of HNK for 3 and 6 h, followed by stimulation of IL-6 (10ng/ml) or IGF-1 (25ng/ml) for 10 and 20 minutes (min). Cell lysates were prepared as described for Western blotting.
Angiogenesis assay
The anti-angiogenic effect of HNK was determined using on In Vitro Angiogenesis Assay Kit (Chemicon, Temecula, CA). Human umbilical vein endothelial cells (HUVEC)
were cultured in the presence or absence of HNK on polymerized matrix gel at 37 ዊ. After only.
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Results
HNK inhibits growth of MM cell lines.
To identify the therapeutic potential of HNK, MM cell lines and normal PBMNCs were cultured with indicated concentration of HNK for 48 h, and growth was determined by colorimetric assays. HNK inhibited the growth of drug sensitive RPMI8226, U266 and MM.1S cells, with fifty percent inhibition (IC 50 ) at 48 h of 8 to 10 µg/ml. HNK also inhibited growth of drug resistant RPMI8226-Dox40, RPMI8226-LR5 and MM.1R cells, with IC 50 values similar to parental drug-sensitive cell lines ( Figure 1A and B). Shorter (3, 6 , and 12 h) exposures to HNK, followed by culturing in media without HNK until 48 h, also induced cytotoxicity (data not shown). Up to 20 µg/ml of HNK did not significantly reduce the viability of normal PBMNCs at 48 h ( Figure 1C ).
HNK is cytotoxic to patient MM cells.
Cytotoxicity of HNK against tumor cells isolated from 6 patients with relapsed Figure 1D ).
HNK induces apoptosis in MM cell lines.
In order to further characterize the cytotoxicity of HNK against MM cell lines, we only.
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HNK induces both caspase-dependent and independent apoptosis.
We next examined the apoptotic pathway induced by HNK. MM.1S cells were treated with 10 µg/ml of HNK for 12 and 24 h. Protein expression of caspase 6, 7, 8, 9, and PARP was then determined by WB, and activated caspase 3 was measured using a flow cytometric assay. Cleavage of caspases 7, 8, 9 and PARP were induced by HNK ( Figure   2B ). Activation of caspase 3 induced by HNK or As 2 
-Bad, Bak, Bax, Bcl-2, and Bcl-xL were unchanged after HNK treatment ( Figure 2E ).
HNK also induced release of mitochondrial pro-apoptotic protein AIF to cytosol ( Figure   2F ). Finally, HNK also induced apoptosis in SU-DHL-4 cells, which are resistant to doxorubicin and As 2 O 3 -induced apoptosis (Table 1) , without associated activation of caspase 3 (data not shown).
Combined with HNK and bortezomib augments inhibition MM.1S cell growth.
Combined treatment of MM.1S cells with HNK and bortezomib enhances the cytotoxicity and induction of apoptosis compared to each drug alone ( Figure 3A Figure 4A and B) . Binding of MM cells to BMSCs derived from 2 MM patients triggers DNA synthesis, which was also abrogated by HNK (Figure 4C and D) .
Importantly, at similar concentrations HNK did not affect the viability of BMSCs, as determined by colorimetric assay (data not shown).
To further delineate the effect of HNK on growth signaling, MM.1S cells were stimulated by IL-6 (10 ng/ml) or IGF-1 (25 ng/ml) for 10 and 20 min following pre-treatment with 10 µg/ml of HNK for 3 and 6 h in 2.5 % FCS. HNK significantly reduced phosphorylation of STAT-3, ERK and Akt induced by IL-6, as well as ERK and Akt induced by IGF-1 ( Figure 5A and B) . Downregulation of gp130 and gp80 were also observed after HNK-treatment ( Figure 5C ).
HNK significantly inhibits angiogenesis of HUVEC.
HUVEC were cultured with 8 µg/ml of HNK for 6 h, and tube formation by Most drugs used to treat MM as well as other malignant diseases induce tumor cell death by activation of caspases and apoptosis. However, recent studies suggest that caspase activation is not the sole pathway for inducing apoptosis by death stimuli [28] [29] [30] .
Caspase-independent apoptosis in vitro can be induced by some clinically available drugs [31] [32] [33] [34] . In MM, apoptosis in RPMI8226 cells and patient MM cells induced by As 2 O 3 is caspase-independent 35 . HNK also induces apoptosis in SU-DHL4 cells, which express low levels of caspase-8 and -3. We therefore further examined HNK-induced caspase-independent AIF/Endo G pathway 34, [36] [37] [38] [39] [40] . In this pathway, death stimuli induce release of AIF and/or Endo G from mitochondria to the cytosol and nucleus, with subsequent chromatin condensation and cell death. During HNK induced apoptosis AIF, but not Endo G, was significantly released from mitochondria to cytosol. There are few reports that apoptosis induced via AIF/Endo G pathway can also be caspase-dependent by showing the release of AIF and Endo G from mitochondria is blocked by z-VAD-fmk 40, 41 . In our study, the release of AIF protein was caspase-independent, since HNK effects on AIF were not blocked by z-VAD-fmk. Finally, since pre-treatment with serine protease inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF) did not inhibit HNK induced apoptosis (data not shown), thus caspase-dependent and -independent cell death pathway only.
For 33, 42, 43 is not likely to mediate HNK-induced apoptosis,
These results indicate HNK induces apoptosis in MM cells via both caspase-dependent and -independent pathways. HNK induces apoptosis in SU-DHL4 cells, which express low levels of caspase-8 and -3 and are resistant to doxorubicin, As 2 O 3 , melphalan, dexamethasone, bortezomib, and revlimid 44 . Therefore, agents such as HNK which kill MM cells via both caspase-dependent and -independent pathways may be particularly useful to overcome drug resistance.
The combination of HNK with bortezomib enhanced cytotoxicity and induction of apoptosis, compared to either drug alone. Importantly, we have previously shown that Hsp27 and Hsp70 are upregulated after bortezomib treatment in MM cells 45, 46 ; since Hsps inhibit apoptotic signaling at several levels [47] [48] [49] only.
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The BM microenvironment confers drug resistance in MM cells 50 . Anti-angiogenesis activity of HNK, evidenced by blocking of VEGF-induced VEGF receptor 2 autophosphorylation and growth inhibition in HUVEC, has been reported 11 . In this study, we also showed that sub-toxic doses of HNK induced inhibition of tube formation of HUVEC, suggesting that HNK inhibits vascular formation in the BM microenvironments.
In conclusion, we have shown that the HNK induces apoptosis via For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From (10µg/ml) in FCS 2.5% containing media for 3 and 6 h. Whole cell lysates were subjected to Western blotting to determine cleavage of caspases and expression of gp80 and gp130. Table 1 only.
